<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
78848-007-01
</NDCCode>
<PackageDescription>
17.6 mL in 1 VIAL (78848-007-01)
</PackageDescription>
<NDC11Code>
78848-0007-01
</NDC11Code>
<ProductNDC>
78848-007
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Trastuzumab
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20200415
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Fareva
</LabelerName>
<SubstanceName>
TRASTUZUMAB
</SubstanceName>
<StrengthNumber>
420
</StrengthNumber>
<StrengthUnit>
mg/17.6mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2022-03-18
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20231231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
15-APR-20
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>